Xin Hu

USPTO Granted Patents = 14 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Fredrick, MD (US) (2019)
Rockville, MD (US) (2023)
Frederick, MD (US) (2019 - 2024)

Company Filing History:

11 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

6 out of 1,153

Vanderbilt University

patents

6 out of 580

The Uab Research Foundation

patents

4. 6 out of 2,595

University of Pennsylvania

patents

5. 3 out of 547

University of Kansas-ku Medical Center Research Institute

patents

6. 2 out of 3,682

The Johns Hopkins University

patents

7. 2 out of 1,269

University of North Carolina at Chapel Hill

patents

8. 1 out of 1

The United States of America, As Represented by Th

patent

9. 1 out of 42

Pontificia Universidad Catòlica De Chile

patents

10. 1 out of 1

The United States of America,as Represented by the Secretary, Department of Health and Human Servic

patent

11. 1 out of 1

Pontifica Universidad Catoclica De Chile

patent

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435047 - c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same (2025-10-07),

2. 12365653 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2025-07-22),

3. 12208093 - Use of low dose emetine for inhibition of human cytomegalovirus (HCMV) (2025-01-28),

4. 12145922 - Selective D3 dopamine receptor agonists and methods of their use (2024-11-19),

5. 11897845 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2024-02-13),

6. 11766423 - 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases (2023-09-26),

7. 11649218 - C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same (2023-05-16),

8. 11634404 - Selective Ddopamine receptor agonists and methods of their use (2023-04-25),

9. 11253511 - Use of low dose emetine for inhibition of human cytomegalovirus (HCMV) (2022-02-22),

10. 11247971 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2022-02-15),

11. 10961200 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-30),

12. 10954228 - 1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-23),

13. 10351532 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2019-07-16),

14. 10202367 - Heterocyclic compounds and methods of use thereof (2019-02-12),

Title: Inventor Xin Hu - Pioneering Innovations in Frederick, MD

Introduction: Xin Hu is a visionary inventor based in Frederick, MD, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xin Hu holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Xin Hu has led numerous projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Xin Hu has collaborated with leading research institutions, universities, and tech companies to bring her ideas to life and make a lasting impact on society.

Conclusion: Xin Hu's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.